Inadequate bioavailability of therapeutic drugs. which is often the consequence of their unacceptable solubility and dissolution rates. is an indisputable operational challenge of pharmaceutical companies due to its detrimental effect on the therapeutic efficacy. Over the recent decades. https://www.campicon.com/